Metabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMT
详细信息 查看全文
- 作者：Zachariah DeFilipp1 ; Rafael F. Duarte2 ; John A. Snowden3 ; Navneet S. Majhail4 ; Diana M. Greenfield5 ; José ; Ló ; pez Miranda6 ; Mutlu Arat7 ; K. Scott Baker8 ; Linda J. Burns9 ; Christine N. Duncan10 ; Maria Gilleece11 ; Gregory A. Hale12 ; Mehdi Hamadani13 ; Betty K. Hamilton4 ; William J. Hogan14 ; Jack W. Hsu15 ; Yoshihiro Inamoto16 ; Rammurti T. Kamble17 ; Maria Teresa Lupo-Stanghellini18 ; Adriana K. Malone19 ; Philip McCarthy20 ; Mohamad Mohty21 ; 22 ; 23 ; Maxim Norkin15 ; Pamela Paplham20 ; Muthalagu Ramanathan24 ; John M. Richart25 ; Nina Salooja26 ; Harry C. Schouten27 ; Helene Schoemans28 ; Adriana Seber29 ; 30 ; Amir Steinberg19 ; Baldeep M. Wirk31 ; William A. Wood32 ; Minoo Battiwalla33 ; Mary E.D. Flowers8 ; Bipin N. Savani34 ; Bronwen E. Shaw13 ; bshaw@doctors.org.uk" class="auth_mail" title="E-mail the corresponding author ; on behalf of the CIBMTR Late Effects ; Quality of Life Working Committee
- 关键词：Metabolic syndrome ; Cardiovascular disease ; Hematopoietic cell transplantation ; Survivorship ; Late effects
- 刊名：Biology of Blood and Marrow Transplantation
- 出版年：2016
- 出版时间：August 2016
- 年：2016
- 卷：22
- 期：8
- 页码：1493-1503
- 全文大小：332 K
文摘
- •
Long-term survivors of HCT have a substantial risk of developing metabolic syndrome and cardiovascular disease.
- •
A collaboration between the CIBMTR and EBMT reviewed the medical literature relevant to these complications.
- •
We provide herein consensus recommendations regarding screening and preventive practices for metabolic syndrome in transplant recipients.